Minoxidil for Hair Loss: How It Works, What to Expect, and Topical vs. Oral
Minoxidil 5% topical, low-dose oral minoxidil (LDOM), realistic regrowth expectations, the shed, side effects, and what stopping does. The evidence-based guide.
Contents (12)
If you started minoxidil six weeks ago and “nothing’s happening,” you’re on track. Visible change takes months, not weeks, and most people who quit, quit before the drug has a chance to work.
Minoxidil is the most-studied non-prescription treatment for pattern hair loss (AGA / FPHL) and the only topical drug FDA-approved for the indication4 . After three decades of use, the picture is reasonably clear: it works for a meaningful fraction of users, the effect is modest, and it stops working when you stop1 .
How minoxidil actually works
Minoxidil is a vasodilator originally developed for severe hypertension. The hair-growth effect was a side effect: oral minoxidil patients grew unwanted body hair (hypertrichosis), which prompted the topical reformulation now sold as Rogaine and generic equivalents1 .
The mechanism in hair follicles isn’t fully settled. The leading model1 :
- Conversion to minoxidil sulfate in the scalp by the enzyme sulfotransferase. Minoxidil sulfate is the active form.
- Prolongation of the anagen (growth) phase of the hair cycle, increasing the proportion of follicles actively producing hair.
- Increased follicle size, converting some miniaturised vellus hairs into thicker terminal hairs.
Sulfotransferase activity varies between individuals. That variation is one of the leading explanations for why some people respond strongly to topical minoxidil and others see little1 .
What the trials show
Topical minoxidil
The pivotal trials that supported FDA approval, and the larger body of work since, show consistent but modest effects.
In the Olsen et al. 2002 randomised trial in men with androgenetic alopecia, after 48 weeks2 :
- 5% topical minoxidil produced significantly greater hair count gains than 2% or placebo.
- Most of the visible gain occurred in the first 16–24 weeks.
- A subset of users (roughly 15–20%) saw clearly noticeable regrowth; the majority saw stabilisation or modest thickening.
The honest summary: most users get a slowdown of loss and modest cosmetic improvement, not dramatic regrowth. The treatment does nothing to the underlying androgenic process; it counteracts the symptom while applied. To attack the cause, you need a 5α-reductase inhibitor like finasteride or dutasteride, covered in our finasteride vs. dutasteride guide.
Low-dose oral minoxidil (LDOM)
Off-label low-dose oral minoxidil (typically 0.25–5 mg daily) has become widely prescribed by dermatologists in the last several years. Reviews of clinical experience and small trials suggest3 :
- Comparable or slightly better efficacy than topical for many users.
- Far better adherence: one pill daily versus twice-daily topical application.
- Different side-effect profile: systemic rather than local.
It’s not FDA-approved for hair loss. It’s prescribed off-label by dermatologists familiar with the dosing protocols.
Topical vs. oral
| Factor | Topical 5% | Oral (low-dose) |
|---|---|---|
| FDA approval for hair loss | Yes (men 5%, women 2% & 5%) | No (off-label) |
| Prescription required | No | Yes |
| Application | Twice daily, must dry | One pill daily |
| Common side effects | Scalp irritation, dryness, itching | Hypertrichosis (body hair), ankle swelling, lightheadedness |
| Time to visible effect | 4–6 months | 4–6 months |
| Cost (typical, monthly) | $15–40 | $10–25 (generic) |
| Adherence in practice | Often poor with twice-daily routine | High with single pill |
What to actually expect
Three things, before you start.
It’s slow. No formulation produces visible change in less than 3 months. Full effect takes 6–12 months. People who quit at week 8 because “nothing happened” are quitting before the drug has had a chance to work.
The first 4–8 weeks may include shedding. A “shed” (temporary increase in hair fall as follicles synchronise into a new growth cycle) is common and not a sign the drug is failing. It usually resolves by month 3. Tressless commenters call this “the dread shed.” It is dreaded, and it is also a normal stage of the drug working.
It only works while you use it. Stop, and within 3–6 months hair returns to where it would have been without treatment. This is the most important thing to understand: minoxidil is maintenance, not cure.
Side effects
Topical
- Scalp irritation, dryness, itching, flaking. Most common, often related to the propylene glycol vehicle in liquid formulations. Foam formulations (which omit propylene glycol) are usually better tolerated.
- Unwanted facial hair, particularly in women. Usually from runoff or hand transfer, not the scalp itself.
Oral
- Hypertrichosis (extra body and facial hair). The most common side effect, dose-dependent. Often manageable at low doses.
- Fluid retention and ankle swelling. Typically mild at low doses; clinicians often co-prescribe a low-dose diuretic if it’s a concern.
- Lightheadedness or palpitations. Uncommon at the low doses used for hair loss.
Anyone considering oral minoxidil should be screened by a clinician for cardiovascular risk factors first.
Combining with other treatments
Minoxidil pairs well with other interventions because it works on a different axis:
- Finasteride or dutasteride blocks the underlying DHT-driven miniaturisation. Combination therapy outperforms either drug alone in trials. Most dermatologists recommend the combination for men with progressive AGA. Details in our finasteride vs. dutasteride guide.
- Microneedling (dermaroller) has been studied as an adjunct to topical minoxidil, with several small trials suggesting improved outcomes. Specifics in our microneedling for hair loss guide.
- Ketoconazole shampoo is sometimes added for its mild anti-androgenic and anti-inflammatory effect, though the evidence is weaker.
When to see a dermatologist
- You’re not sure your diagnosis is pattern hair loss (see our types of hair loss guide and diagnostic guide)
- Sudden, rapid, or patchy loss, where different conditions need different treatments
- Scalp redness, scaling, itching, pain, or visible scarring (these point away from minoxidil-responsive conditions)
- You’re considering oral minoxidil, which should be prescribed and monitored
- You’ve used topical minoxidil correctly for 6+ months with no response, in which case a clinician can reassess and consider escalation
What this article doesn’t cover
We haven’t covered the niche use of minoxidil for non-AGA conditions (alopecia areata, hypotrichosis, eyebrow restoration), the high-strength compounded formulations that some online clinics sell, or the specific clinical protocols dermatologists use for LDOM dose escalation. Each warrants its own piece. This article is also not personal medical advice; talk to a clinician before starting any prescription medication.
If hair loss is affecting your wellbeing, it’s worth speaking to a GP or dermatologist, and reaching out to a peer community helps too. You’re not making this up, and you’re not alone in finding it hard.
Frequently asked questions
How long until I see results from minoxidil?
Most users see no visible change for the first 3 months and may experience a temporary shed in weeks 4–8. Visible improvement typically appears between months 4 and 6, with full effect by 12 months. Quitting before 6 months is the most common reason people conclude minoxidil didn't work for them.
Does minoxidil regrow a fully bald scalp?
No. Minoxidil works on miniaturised hair follicles that are still alive but producing thinner hair. Once a follicle is fully dormant or scarred (as in late-stage pattern baldness), minoxidil cannot regrow hair there. It's most effective on the crown and frontal areas where thinning is in progress, not on long-bald regions.
What happens if I stop using minoxidil?
Within 3–6 months of stopping, any minoxidil-driven gains will reverse and hair will return to the trajectory it would have been on without treatment. Minoxidil does not cure androgenetic alopecia; it counteracts the symptom while in use.
Is the 5% formulation always better than 2%?
5% has shown greater efficacy in head-to-head trials and is the standard for men. For women, both 2% and 5% are FDA-approved; the 5% foam (once daily) is now widely used and generally well tolerated, though some women experience more irritation at 5%.
Is oral minoxidil safer than topical?
Different rather than safer. Topical minoxidil's side effects are usually local (scalp irritation). Oral minoxidil's are systemic (extra body hair, potential fluid retention). At the low doses used for hair loss (0.25–5 mg/day), serious cardiovascular effects are uncommon, but it should only be used under medical supervision with appropriate baseline screening.
Can I use minoxidil and finasteride together?
Yes, and combination therapy outperforms either drug alone in published trials. They work via different mechanisms (minoxidil prolongs the growth phase; finasteride blocks DHT, the androgen driving miniaturisation). Most dermatologists recommend the combination for men with progressive AGA.
Will minoxidil work for diffuse thinning?
It works on the miniaturisation that drives diffuse thinning in androgenetic alopecia. Whether it'll work for you depends on whether your diffuse thinning is AGA versus telogen effluvium versus another cause, since minoxidil only addresses the AGA pattern. Diagnosis matters; if you're not sure, see our types of hair loss guide and consider seeing a dermatologist before committing to a 6–12 month minoxidil trial.
What is the 'dread shed' on minoxidil?
A temporary increase in hair fall during the first 4–8 weeks of starting minoxidil, as follicles synchronise into a new growth cycle. It's a sign the drug is working, not failing. It usually resolves by month 3. Quitting in the middle of the dread shed is common, and exactly the wrong move.
References
- Minoxidil and its use in hair disorders: a review (Suchonwanit et al., 2019) , Drug Design, Development and Therapy
- A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men (Olsen et al., 2002) , Journal of the American Academy of Dermatology
- Low-dose oral minoxidil for treatment of androgenetic alopecia (Randolph & Tosti, 2021) , Journal of the American Academy of Dermatology
- FDA label: Rogaine (minoxidil topical solution) , U.S. Food and Drug Administration
More in Treatments
Minoxidil vs. Finasteride: Which Should You Take for Hair Loss?
Minoxidil and finasteride are the two first-line treatments for pattern hair loss. Different mechanisms, different efficacy, different side-effect profiles. The honest comparison, and why most men take both.
Finasteride vs. Dutasteride: Which Should You Take for Hair Loss?
Finasteride and dutasteride are both 5α-reductase inhibitors used for male pattern hair loss. They're not interchangeable: efficacy, side effects, and FDA status differ. The honest comparison.
Microneedling for Hair Loss: Does It Actually Work?
Microneedling for androgenetic alopecia: what the trials actually show, why it works as an adjunct to minoxidil, the at-home vs. in-office difference, and what the risks are.